BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Prognosis
210 results:

  • 1. colorectal neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasm: Prognostic factors and PD-L1 expression.
    Ho YH; Hsu CY; Yau Li AF; Liang WY
    Hum Pathol; 2024 Mar; 145():80-85. PubMed ID: 38423221
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. High-throughput sequencing and in-silico analysis confirm pathogenicity of novel MSH3 variants in African American colorectal cancer.
    Rashid M; Rashid R; Gadewal N; Carethers JM; Koi M; Brim H; Ashktorab H
    Neoplasia; 2024 Mar; 49():100970. PubMed ID: 38281411
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mismatch Repair Deficiency as a Predictive and Prognostic Biomarker in Endometrial cancer: A Review on Immunohistochemistry Staining Patterns and Clinical Implications.
    Addante F; d'Amati A; Santoro A; Angelico G; Inzani F; Arciuolo D; Travaglino A; Raffone A; D'Alessandris N; Scaglione G; Valente M; Tinnirello G; Sfregola S; Padial Urtueta B; Piermattei A; Cianfrini F; Mulè A; Bragantini E; Zannoni GF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256131
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
    Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
    [No Abstract]    [Full Text] [Related]  

  • 5. Mismatch Repair Protein Deficiency Does Not Affect Disease Free Survival in Type I Endometrial Carcinoma.
    Angelina YA; Tjokroprawiro BA; Sandhika W
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3229-3234. PubMed ID: 37774076
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mismatch Repair Deficiency in Biliary Tract cancer: Prognostic Implications and Correlation with Histology.
    Vivaldi C; Genovesi V; Ugolini C; Bernardini L; Casadei-Gardini A; Formica V; Salani F; Orsi G; Massa V; Cacciato-Insilla A; Caccese M; Cesario S; Andrikou K; Graziani J; Campani D; Vasile E; Fontanini G; Fornaro L; Masi G
    Oncology; 2024; 102(2):157-167. PubMed ID: 37699372
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types.
    Bartels S; Grote I; Wagner M; Boog J; Schipper E; Reineke-Plaass T; Kreipe H; Lehmann U
    Cancer Med; 2023 Aug; 12(16):16707-16715. PubMed ID: 37376830
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dihydropyrimidine Dehydrogenase (DPD) as a Bridge between the Immune Microenvironment of Colon cancers and 5-FU Resistance.
    Cui Z; He S; Wen F; Lu L; Xu L; Wu H; Wu S
    Front Biosci (Landmark Ed); 2023 Apr; 28(4):80. PubMed ID: 37114540
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 10. A robust microsatellite instability detection model for unpaired colorectal cancer tissue samples.
    Zhang Z; Wan H; Xu B; He H; Shan G; Zhang J; Wu Q; Li T
    Chin Med J (Engl); 2023 May; 136(9):1082-1088. PubMed ID: 37022939
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.
    Kansikas M; Vähätalo L; Kantelinen J; Kasela M; Putula J; Døhlen A; Paloviita P; Kärkkäinen E; Lahti N; Arnez P; Kilpinen S; Alcala-Repo B; Pylvänäinen K; Pöyhönen M; Peltomäki P; Järvinen HJ; Seppälä TT; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Nyström M
    Cancer Res Commun; 2023 Mar; 3(3):361-370. PubMed ID: 36875157
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. An exploration of gastric cancer with heterogeneous mismatch repair status.
    Wang X; Jiang K; Hu Y; Zhao X; Yin L; Diao X; Ma X; Xu Y; Bai Y; Zhang Y; Li Z; Sun Y
    Virchows Arch; 2023 Mar; 482(3):517-523. PubMed ID: 36754896
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Microsatellite instability in gastric cancer is a predictor of a favorable prognosis].
    Danilova NV; Chayka AV; Khomyakov VM; Oleynikova NA; Andreeva YY; Malkov PG
    Arkh Patol; 2022; 84(6):5-15. PubMed ID: 36469712
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The genetic alterations of rectal neuroendocrine tumor and indications for therapy and prognosis: a systematic review.
    Li K; Liu Y; Han J; Gui J; Zhang X
    Endocr J; 2023 Feb; 70(2):197-205. PubMed ID: 36403965
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic landscape of microsatellite instability in Chinese tumors: A comparison of Chinese and TCGA cohorts.
    Li Z; Jia Y; Zhu H; Yuan H; Xing X; Xin Y; Ma T; Pang F; Zhang Y; Hu Y; Jia S; Ji J
    Int J Cancer; 2022 Oct; 151(8):1382-1393. PubMed ID: 35567574
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The clinical features and management of Lynch syndrome-associated ovarian cancer.
    Ran X; Jing H; Li Z
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma.
    Ye S; Zhou S; Zhong S; Shan B; Jiang W; Yang W; Cai X; Yang H
    BMC Cancer; 2022 Apr; 22(1):449. PubMed ID: 35461222
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
    Sahin I; Saat H
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 11.